⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EVGN News
EVOGENE LTD.
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AZN
MRK
JNJ
PFE
ABBV
GSK
ALLR
SNY
CURI
ORIC
EXEL
ABSI
LLY
TLX
FPH
BMY
SNX
XNCR
ZENA
ARVN
MGNX
DASH
VERU
GILD
EVGN
GEN
AMGN
MIR
RXRX
BG
MTX
BIO
Evergen Named “Best Overall MedTech Company” in 10th Annual MedTech Breakthrough Awards Program
globenewswire.com
EVGN
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
prnewswire.com
EVGN
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
prnewswire.com
EVGN
Sol-ti® Highlights Expanded Leadership Team to Support Brand Growth
prnewswire.com
SSTI
WMT
SBUX
KODK
EVGN
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
prnewswire.com
EVGN
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
EVGN
Evogene Releases CEO Letter to Shareholders
prnewswire.com
EVGN
AI in Biotechnology Market Size to Reach USD 1,971 Million by 2031 | Valuates Reports
prnewswire.com
RXRX
EVGN
BNTX
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
prnewswire.com
EVGN